Drug Database
AL

albumin (albumin, Qiombiotec)

✓ Approved

Quimbiotec · 细胞治疗 · 细胞治疗

什么是 albumin?

albumin 是一种细胞治疗,由Quimbiotec研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

商品名albumin, Qiombiotec
公司Quimbiotec
药物类别细胞治疗
给药途径Injectable (Others), Intravenous (IV)
状态Approved

治疗适应症

albumin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Metabolism and nutrition disordersHypoalbuminaemia✓ Approved

相关研究文献

PubMedBMC cancer2026-11-19

Treatment outcomes and immuno-nutritional biomarkers in patients with cervical esophageal squamous cell carcinoma treated with induction chemotherapy.

Ono Takeharu T, Nakata Yasunori Y, Chitose Shun-Ich SI, Sueyoshi Shintaro S et al.

Cervical esophageal squamous cell carcinoma arises below the upper esophageal sphincter, often causing dysphagia due to tumor progression. Therefore, some patients with cervical esophageal squamous cell carcinoma become malnourished. Due to its low incidence, limited information is available on prognostic immune-nutritional biomarkers. We retrospectively reviewed 47 patients with resectable cervical esophageal squamous cell carcinoma who underwent induction chemotherapy. Prognostic biomarkers were selected based on their 5-year area under the curve values. The association between the biomarkers and disease-free survival or overall survival was evaluated in univariable and multivariable analyses. The C-reactive protein-albumin-lymphocyte index and high-sensitivity modified Glasgow prognostic score were significantly associated with the induction chemotherapy response. Both the C-reactive protein-albumin-lymphocyte index and the high-sensitivity modified Glasgow prognostic score were significantly associated with disease-free survival and overall survival in univariable analysis. C-reactive protein-albumin-lymphocyte indices were significantly associated with disease-free survival and overall survival in multivariable analysis. The C-reactive protein-albumin-lymphocyte index is a useful prognostic treatment outcome biomarker in patients with cervical esophageal squamous cell carcinoma undergoing induction chemotherapy.

PMID 43052838
阅读全文 →
PubMedBMC cancer2026-11-19

Pulmonary embolism in lung cancer: a retrospective exploratory study.

Shang Junyi J, Wu Zhuhua Z, Jiang Miao M, Yuan Lin L et al.

Lung cancer is associated with a high risk of venous thromboembolism, and pulmonary embolism (PE) is a critical complication. The synchronous diagnosis of PE at the initial presentation of lung cancer presents diagnostic challenges and affects management. The predictive factors for this dual diagnosis remain poorly defined. A retrospective comparative study was conducted on 251 newly diagnosed lung cancer patients, including 79 with concurrent PE (observation group) and 172 without PE (control group). Demographic, clinical, laboratory, and tumor - related data were collected. Statistical analysis included univariate and multivariate logistic regression to seek independent risk factors and ROC curve analysis to evaluate their potential predictive performance. Univariate analysis revealed significant differences in multiple variables, including pericardial/pleural effusion, smoking index, hematologic parameters, coagulation markers, D - dimer, liver enzymes, albumin, and tumor markers (CEA, CA125, CA199) (P < 0.05). Multivariate logistic regression analysis indicated that smoking index, hemoglobin, PT, direct bilirubin, albumin, and CEA may be independent risk factors for synchronous pulmonary embolism in lung cancer patients. The combination of the six independent risk factors also demonstrated significant predictive potential (AUC = 0.857, sensitivity 79.1%, specificity 79.7%). Lung cancer patients presenting with synchronous PE exhibit a distinct clinical phenotype. The smoking index, hemoglobin, PT, direct bilirubin, albumin, and CEA may be independent predictive factors. D - dimer is a well diagnostic marker. These findings suggest a practical framework to help guide clinical suspicion and encourage targeted diagnostic evaluation for PE at the initial diagnosis of lung cancer, contributing to improved early intervention and patient outcomes.

PMID 43052863
阅读全文 →
PubMedNature biomedical engineering2026-11-19

Designer mucin-responsive nanomedicine for enhanced solid tumour penetration and therapy.

Yu Na N, Gong Ningqiang N, Liu Juan J, Zhong Haiping H et al.

While nanomedicines hold great promise for solid tumour therapy, their penetration and access to tumour cells is limited by large glycosylated proteins called mucins that are enriched in the tumour microenvironment. Here we show that mucins induce the disassembly of self-assembled mPEG-polyester micellar nanoparticles into smaller unimers. Leveraging this finding, we designed a mucin-responsive, paclitaxel-conjugated nanomedicine (mrPNM) whose unimers are capable of escaping the mucin-binding barrier. Following intravenous injection, this designer mucin-responsive nanomedicine exhibited markedly deeper penetration than the mucin-nonresponsive nanomedicine and albumin, resulting in 3.9- and 1.5-fold increases in tumour cell delivery, respectively, in a pancreatic mouse tumour model. The mrPNMs also achieved superior tumour growth inhibition compared to both the mucin-nonresponsive nanomedicine and Abraxane, the FDA-approved nanoparticle albumin-bound paclitaxel, in three solid tumour models. The mucin-responsive nanomedicine platform could provide a general strategy for improving the treatment of solid tumours.

PMID 43052497
阅读全文 →
PubMedVeterinary medicine and science2026-11-19

Early Changes in Serum Protein Electrophoresis and Gamma Globulin during Initial 4 Weeks of Remdesivir Therapy in FIP Cats.

Khalili Kosar K, Cheraghi Hadi H, Saljooghian Isfahani Mohammad Hossein MH

Feline infectious peritonitis (FIP) is a fatal multisystem inflammatory disorder of cats that was historically considered untreatable before the emergence of direct-acting antivirals. The objective of the study was to evaluate early serial changes in serum protein electrophoresis (SPE) patterns in cats treated with remdesivir for FIP, emphasizing gamma-globulin concentrations and percentages. Animals included eighteen client-owned cats diagnosed with FIP based on clinical presentation, standard clinicopathological profiles, and confirmatory RT-PCR. Cats received remdesivir for 4 weeks and were monitored weekly through clinical examinations and laboratory evaluations. Blood samples were collected at baseline (prior to treatment initiation) and weekly for 4 weeks. The SPE analyzed the blood taken every week for the serum protein fractions, such as albumin and the different globulins, namely α1-, α2-, β1-, β2-, and γ-globulins. The albumin to globulin ratio (A/G ratio) was also determined. Gamma globulins were found to be significantly reduced from a median of 3.1 g/dL at week 2 to a median of 2.2 g/dL at the end of week 4 (p < .05) in cats that showed clinical response. Notably, ROC curve analysis identified that a gamma-globulin percentage <23% at week 4 and 18.96% by week 6 (AUC = 0.9105) was strongly associated with complete clinical recovery and sustained relapse-free remission. Serial monitoring of serum protein electrophoresis, particularly longitudinal trends in gamma-globulin percentages and the A/G ratio, provides an objective, practical biomarker strategy to evaluate treatment response and guide the safe timing of antiviral therapy cessation in cats with FIP.

PMID 43052221
阅读全文 →
PubMedBMC gastroenterology2026-11-19

A multicenter study of capsule endoscopy in preschool children in China.

Jin Meng M, Mi Mingran M, Gong Youzhe Y, Liao Weiwei W et al.

To evaluate the safety and clinical utility of capsule endoscopy in preschool-aged children. A multicenter retrospective study design was used, including data from eight specialized pediatric hospitals in China. Children aged < 6 years who were hospitalized and underwent capsule endoscopy between January 2020 and August 2025 were included. This study included 155 patients (mean age 56.9 ± 14.2 months). The most common indication was chronic abdominal pain (50.97%), followed by suspected inflammatory bowel disease (22.58%), gastrointestinal bleeding (16.13%), and unexplained anemia (8.39%). Abnormal findings were identified in 69 cases, which established a definitive diagnosis in 55 patients (diagnostic yield, 35.5%), including 15 with isolated small-bowel disease. Capsule retention occurred in three patients with Crohn's disease. Fifty patients swallowed the capsule independently, while others required endoscopic placement; endoscopic assistance increased the success rate of capsule delivery to 100% in preschool children. When preschool children exhibited elevated inflammatory markers (C-reactive protein(CRP) 6 mg/L [interquartile range (IQR), 0.81-23 mg/L] vs. 0.95 mg/L [IQR, 0.51-3.58 mg/L]; erythrocyte sedimentation rate(ESR) 16 mm/h [IQR, 6-27 mm/h] vs. 7 mm/h [IQR, 4-14 mm/h]), lower albumin levels (38.47 ± 8.83 g/L vs. 42.50 ± 4.92 g/L), and intestinal wall thickening on imaging (56.36% vs. 20.00%), the diagnostic positive rate significantly increased. Capsule endoscopy is safe for preschool children. Capsule retention is mainly associated with underlying diseases. Capsule endoscopy is recommended to assess small-bowel lesions in children with elevated inflammatory markers, reduced albumin levels, or radiographic evidence of bowel wall thickening, facilitating early diagnosis and treatment.

PMID 43052746
阅读全文 →
PubMedClinical cardiology2026-11-19

Predictive Value of Serum Fibrinogen-to-Albumin Ratio in Young Patients With Coronary Heart Disease and its Correlation With Coronary Lesion Severity.

Gao Yi-Meng YM, Cai Tian-Zhi TZ, Ma Hong-Lan HL

Predictive value of Fibrinogen-to-Albumin Ratio (FAR) in young patients with coronary heart disease (CHD) and its correlation with the severity of coronary artery lesions. We enrolled 472 young patients hospitalized at our hospital from August 2013 to August 2024 who underwent coronary angiography (CAG) and divided into a CHD group (n = 212) and a non-CHD group (n = 260) based on CAG results. Univariate analysis was conducted on all variables. Subsequently, Lasso regression analysis (LASSO) and bidirectional stepwise logistic regression were used to identify the independent risk factors to construct a prediction model. ROC, calibration, and clinical decision curves evaluated model performance. CHD patients were grouped by Gensini tertiles to compare FAR differences, and ROC curve analyzed FAR's predictive value for moderate-to-severe stenosis. Univariate analysis showed statistically significant differences in multiple indicators including FAR (p < 0.05). Finally, seven indicators including FAR were included to establish the model. The results of ROC curve analysis showed that FAR and joint mode had predictive value for CHD (p<0.05), The AUC of FAR was 0.643, and that of the combined model was 0.847. FAR was positively correlated with Gensini score (rs = 0.215, p < 0.001). FAR was positively correlated with the Gensini score (rs = 0.215, p < 0.001), showed an upward trend with increasing lesion severity (p = 0.046), and yielded an AUC of 0.596 for predicting moderate-to-severe stenosis (p < 0.05). FAR and the prediction model have predictive value for CHD in young adults; FAR has limited predictive performance for the severity of coronary artery lesions and can serve as an auxiliary reference indicator.

PMID 43053621
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多albumin